A New Treatment for Aggressive Breast Cancer

Aug 21, 2026

Researchers tested a new combination of two cancer drugs — sacituzumab govitecan and pembrolizumab — as the first treatment for patients with PD-L1-positive advanced TNBC. PD-L1 is a protein on some cancer cells that interacts with the immune system.

Reported by

Reviewed by

You May Also Like